Knowledgepie Private Limited

A cutting-edge biotechnology company specializing in innovative solutions for medical imaging.

We are developing alternative MRI contrast agents to improve safety, sustainability, and clinical reliability. Our team is driven by a mission to revolutionize cancer detection through advanced nanotechnology.

+2 Patents

11+ Publications

3+ Book Chapters

Our Mission

To innovate safer contrast agents for cancer detection, prioritizing patient safety, enhancing diagnostic precision, and redefining global cancer care through advanced research, ethical practices, and collaboration with healthcare professionals.

Our Technology

Our developed technology is capped with biocompatible molecules forming stable aqueous solutions. It is non-toxic as certified by GLP and Genotoxicity studies. Synthesis is facile, aqueous, thermo-free, and single-step.

Our Product

Xeuj^® — a patented nanoparticle-based contrast agent targeting renal impaired patients where GBCA is banned by FDA. An iron-based, NSF-free alternative.

Our Flagship Product

Xeuj^®

Our flagship product “Xeuj^®” is a patented nanoparticle-based contrast agent, specifically targeting renal impaired patients where GBCA is banned by FDA.

Patented NSF-Free Iron-Based Eco-Friendly Make in India

Applications

Where Xeuj^® Makes a Difference

Magnetic Resonance Imaging (MRI) Enhancement

Improves visibility and contrast in MRI scans by altering tissue magnetic properties.
Detection & Characterization of Tumors

Crucial for distinguishing tumor tissues from healthy tissue, aiding in diagnosis and treatment planning.
Safe for Renal Impaired Patients

Designed specifically for patients with kidney conditions where traditional contrast agents are contraindicated.